Ilias K. Gartzonikas

Ilias K. Gartzonikas

Auto-generated profile, based on publicly available information

Ilias K. Gartzonikas

Second Department of Cardiology, University of Ioannina Medical School, University Campus, Ioannina, Greece

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
IGIlias K. Gartzonikas
Ilias K. Gartzonikas
KNKaterina K. Naka
Katerina K. Naka
AAAris Anastasakis
Aris Anastasakis

3 May 2023 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
Ioannis LeontsinisIoannis Leontsinis
Ioannis Leontsinis
DFDimitrios Farmakis
Dimitrios Farmakis
DADimitrios Avramidis
Dimitrios Avramidis
EAEirini Andrikou
Eirini Andrikou
AVAngeliki Valatsou
Angeliki Valatsou
KTKonstantinos Tsioufis
Konstantinos Tsioufis
Cardiovascular disease is commonly accompanied by renal dysfunction. Multimorbidity in hospitalized patients impacts unfavorably on prognosis and hospital stay. We aimed to illustrate the contemporary burden of cardiorenal morbidity across inpatient cardiology care in Greece. The Hellenic Cardiorenal Morbidity Snapshot (HECMOS) used an electronic platform to collect demographic and clinically relevant information about all patients hospitalized on the 3rd of March 2022 in Greece. The participating institutions covered all levels of inpatient cardiology care and most of the country's territories in order to collect a real-world, nation representative sample. 923 patients (males 68.4%, median age 73ys ± 14.8) were admitted in 55 different cardiology departments. 57.7% of the sample were older than 70 years of age. Hypertension was highly prevalent, present in 66% of cases. History of chronic HF, DM, AF and CKD was present in 38%, 31.8%, 30% and 26% respectively. 64.1% of the sample exhibited at least one of these four entities. Accordingly, a combination of at least 2 of them was recorded in 38.7%, of at least three in 18.2% whereas 4.3% of the sample combined all four morbid conditions in their past medical history. The most common combination was the coexistence of HF-AF accounting for 20.6% of the sample. 9 out of 10 non-electively admitted patients were hospitalized due to acute HF (39.9%), ACS (33.5%) or tachyarrhythmias (13.2%). HECMOS participants carried a remarkable burden of cardio-reno-metabolic disease. HF in conjunction with AF were found to be the most prevalent combination among the studied cardiorenal nexus of morbidities in the whole study population.

10 September 2023 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
OKOlga Kardakari
Olga Kardakari
CBChristos E. Ballas
Christos E. Ballas
LLLampros Lakkas
Lampros Lakkas
IGIlias Gartzonikas
Ilias Gartzonikas
SGSotiria Giannou
Sotiria Giannou
CKChristos S Katsouras
Christos S Katsouras

1 October 2025 in American Journal of Case Reports
Verified
Journal Article
Open access
VBVasileios Bouratzis
Vasileios Bouratzis
CKChristos S. Katsouras
Christos S. Katsouras
CFChristos Floros
Christos Floros
KNKaterina K. Naka
Katerina K. Naka
LLLampros Lakkas
Lampros Lakkas
LMLampros K. Michalis
Lampros K. Michalis
BACKGROUND Managing acute coronary syndrome in cancer patients poses significant challenges for cardiologists, who often encounter various complications. However, there are multiple therapeutic strategies available. The key lies in identification of the target lesion and early restoration of antegrade blood flow in cases in which it is affected. CASE REPORT We present a case of a 70-year-old man with a medical history of hypertension, type II diabetes mellitus, bioprosthetic aortic valve, coronary artery disease with prior PCI to the LAD, and metastatic prostate cancer who presented with chest pain and shortness of breath. The patient was hemodynamically unstable, with elevated lactates and troponin levels. He was diagnosed with cardiogenic shock secondary to N-STEMI. Coronary angiography revealed a high thrombotic burden at the LM bifurcation, which was managed with balloon angioplasty and medical therapy without stent implantation. Intravascular imaging with IVUS was performed 2 days later, which showed no dissections or significant stenosis. A conservative management strategy was implemented. CONCLUSIONS Cardiogenic shock is a life-threatening complication of N-STEMI, necessitating urgent coronary angiography and immediate revascularization. In certain cases, particularly those involving active malignancy, plain balloon angioplasty combined with optimal medical therapy can be a viable alternative to stent placement. Intravascular imaging assists in making the final decision. Cancer should not be considered a contraindication for invasive treatment in patients presenting with acute coronary syndrome.